BCL11A and neurodevelopmental disorder: A number of pathogenic de novo deletion, loss-of-function, and missense variants impacting BCL11A have been reported in individuals diagnosed with a distinct neurodevelopmental disorder that also displays persistence of HbF [16–22,25].